{
    "id": 19436,
    "fullName": "NUAK1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "NUAK1 (ARK5) over exp indicates an over expression of the NUAK1 (Ark5) protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 9891,
        "geneSymbol": "NUAK1",
        "terms": [
            "NUAK1",
            "ARK5"
        ]
    },
    "variant": "over exp",
    "createDate": "03/10/2016",
    "updateDate": "07/02/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4979,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study ON123300 inhibited growth of multiple myeloma cells with over expression of Nuak1 (Ark5) in cell culture and in cell line xenograft models (PMID: 26873845).",
            "molecularProfile": {
                "id": 19845,
                "profileName": "NUAK1 over exp"
            },
            "therapy": {
                "id": 3705,
                "therapyName": "ON123300",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4822,
                    "pubMedId": 26873845,
                    "title": "Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26873845"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 19845,
            "profileName": "NUAK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}